Pure Global
NCT05480020

Probiotic Toothpaste for Microbial Colonization

Colonisation Efficacy of Streptococcus Salivarius M18 Toothpaste
John Hale·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
Streptococcus salivarius M18 toothpaste
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
John Hale
Funder
BLIS Technologies Limited
Location
Dunedin, New Zealand
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2022
End date
Oct 01, 2022
Enrollment
30 participants
Primary outcome

Change in Microbial colonization from baseline (Day 0) to 1 hour,Change in Microbial colonization from baseline (Day 0) to 8 hours,Change in Microbial colonization from baseline (Day 0) to 24 hours,Change in Microbial colonization from baseline (Day 0) to 24 hours post last dose

Summary

The aim of this study is to evaluate the colonization efficacy of probiotic toothpastes in
 healthy adults

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05480020
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05480020 through Pure Global AI's free database. This phase not specified trial is sponsored by John Hale and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.